Why the government’s latest funding push is critical to the ...
Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa
Newsletters and Deep Dive digital magazine
Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa
For decades, the pharmaceutical industry has relied on accelerated development and manufacturing timelines to bring new therapies to patients quickly.
The term 'patient centricity' has undergone a radical evolution over recent years.
Bayer Oncology's strategy has led to strong showings in small molecules and radiotherapies. Now they're on the hunt for ADCs, bispecifics, and more.
Discover what clinicians can do to foster more patient-centred psychiatric care in a Q&A with neuropsychiatric physician assistant Rebecca Barbee.
Editor's Picks
Newsletters and Deep Dive
digital magazine